Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,000
Closed -$75K 685
2016
Q4
$75K Sell
2,000
-100
-5% -$3.64K ﹤0.01% 382
2016
Q3
$77K Buy
+2,100
New +$70.5K ﹤0.01% 373
2016
Q2
Sell
-46,800
Closed -$1.46M 542
2016
Q1
$1.46M Buy
46,800
+43,200
+1,200% +$1.32M 0.04% 204
2015
Q4
$121K Buy
3,600
+200
+6% +$7.43K ﹤0.01% 305
2015
Q3
$128K Sell
3,400
-600
-15% -$24.5K ﹤0.01% 300
2015
Q2
$193K Buy
4,000
+200
+5% +$10.3K ﹤0.01% 305
2015
Q1
$190K Buy
3,800
+600
+19% +$32.5K ﹤0.01% 323
2014
Q4
$210K Buy
+3,200
New +$223K 0.01% 316

Other funds holding NOV

James Investment Research's NOV Position: Q1 2017 in Review

James Investment Research sold out of NOV (NOV) in Q1 2017, closing a stake of 2,000 shares — an estimated $75K sold.

James Investment Research first reported a position in NOV in Q4 2014 and held it in 8 quarters. The position peaked at $1.46M in Q1 2016. 640 funds tracked by Wall St. Rank hold NOV as of Q1 2017.

  • James Investment Research reported no remaining NOV position as of Q1 2017 after selling out during the quarter.
  • James Investment Research sold 2,000 NOV shares in Q1 2017, an estimated $75K.
  • James Investment Research first reported a position in NOV in Q4 2014 and held it in 8 quarters.
  • James Investment Research's NOV position peaked at $1.46M in Q1 2016.
  • 640 funds tracked by Wall St. Rank held NOV as of Q1 2017.

Based on James Investment Research's 13F filing for Q1 2017, filed 21 Apr 2017.